FDA Inspection 1190200 — Syngene International Limited
The FDA completed an inspection of Syngene International Limited on October 28, 2022 in Bengalore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 28, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bengalore (India)
Additional Details
Clinical BA/BE